NCT02299544 - BlueWind Medical System for the Treatment of Patients With OAB | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 31, 2018

Study Completion Date

December 31, 2018

Conditions

Over Active Bladder

Interventions

DEVICE

BlueWind Medical system

The BlueWind Medical System is intended for the treatment of patients with overactive bladder (OAB) including urinary urgency frequency and urge incontinence.

Trial Locations (6)

Unknown

Catharina Ziekenhuis, Eindhoven

Maastricht UMC, Maastricht

Radboud university medical center Department of Urology, Nijmegen

Southmead Hosital, Bristol

College Hospital and National Hospital for Neurology and Neurosurgery, London

St. Mary's Hospital, Imperial College, London